Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Cybin Inc. < Previous 1 2 3 4 5 6 Next > Cybin Inc. Presents CYB003 Preclinical Data at Neuroscience 2022 November 15, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Reports Second Quarter Financial Results and Recent Business Highlights November 14, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Provides Progress Update on its CYB004-E Phase 1 Trial November 10, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events November 03, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Scientific Presentation at the 5th Annual Neuropsychiatric & Psychedelics Drug Development Summit November 01, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin’s EMBARK Program Announces Graduation of Facilitators October 27, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin & The Chopra Foundation Recognize World Mental Health Day October 10, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Provides Update on its Intellectual Property Portfolio October 06, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds September 27, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Participate in Upcoming Scientific and Investor Conferences September 21, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Achieves Research and Development Milestones Ahead of Projected Timelines September 20, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Final Adelia Milestone Achievement August 31, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Announces First Participants Dosed in its Phase 1/2a Trial of CYB003 for the Treatment of Major Depressive Disorder August 30, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Participate in the H.C. Wainwright 24th Annual Global Investment Conference August 25, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial August 17, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Results of Shareholders’ Meeting August 15, 2022 From Cybin Inc. Via Business Wire Tickers CYBN CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program August 08, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights August 08, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at the Canaccord Genuity 42nd Annual Growth Conference July 28, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Date of Annual Meeting of Shareholders July 25, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical July 11, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Additional Adelia Milestone Achievement June 27, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder June 27, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights June 22, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin to Present at the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022 June 16, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Receives Institutional Review Board Approval for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder June 09, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Acquires DMT Clinical Study from Entheon Biomedical June 07, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Additional Adelia Milestone Achievements June 03, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Roster of 28 Expert Faculty and Advisors for its EMBARK Psychedelic Facilitator Training Program June 03, 2022 From Cybin Inc. Via Business Wire Tickers CYBN Cybin Announces Publication in Frontiers in Psychology Journal Introducing EMBARK, an Integrative Model of Psychedelic Therapy June 02, 2022 From Cybin Inc. Via Business Wire Tickers CYBN < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.